Abstract
A series of Schiff bases of menthone has been synthesized using an appropriate synthetic route and characterized using Thin Layer Chromatography and spectral analysis. The synthesized compounds were evaluated for anticonvulsant activity against maximal electro shock (MES) and strychnine induced seizures model in rats. The neurotoxicity and behavioral depressant studies were also carried out using rotorod and tail suspension methods. Results obtained show that, 84% of the compounds afforded significant protection in the MES screen whereas none of them found to be active in strychnine induced seizures. Schiff base with napthyl amine was found to be most active in the series showing activity in the dose of 10 mg/kg in MES test. Majority of the compounds were found to be active in behavioral depressant screening.
Keywords: Schiff base, anticonvulsant activity, menthone, behavioral depressant activity
Central Nervous System Agents in Medicinal Chemistry
Title: Synthesis and Evaluation of Schiff Bases for Anticonvulsant and Behavioral Depressant Properties
Volume: 7 Issue: 3
Author(s): Jainendra S. Jain, Radheshyam S. Srivastava, Navneet Aggarwal and Reema Sinha
Affiliation:
Keywords: Schiff base, anticonvulsant activity, menthone, behavioral depressant activity
Abstract: A series of Schiff bases of menthone has been synthesized using an appropriate synthetic route and characterized using Thin Layer Chromatography and spectral analysis. The synthesized compounds were evaluated for anticonvulsant activity against maximal electro shock (MES) and strychnine induced seizures model in rats. The neurotoxicity and behavioral depressant studies were also carried out using rotorod and tail suspension methods. Results obtained show that, 84% of the compounds afforded significant protection in the MES screen whereas none of them found to be active in strychnine induced seizures. Schiff base with napthyl amine was found to be most active in the series showing activity in the dose of 10 mg/kg in MES test. Majority of the compounds were found to be active in behavioral depressant screening.
Export Options
About this article
Cite this article as:
Jain S. Jainendra, Srivastava S. Radheshyam, Aggarwal Navneet and Sinha Reema, Synthesis and Evaluation of Schiff Bases for Anticonvulsant and Behavioral Depressant Properties, Central Nervous System Agents in Medicinal Chemistry 2007; 7 (3) . https://dx.doi.org/10.2174/187152407781669143
DOI https://dx.doi.org/10.2174/187152407781669143 |
Print ISSN 1871-5249 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6166 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Central Sensitisation Phenomena in Primary Headaches: Overview of a Preventive Therapeutic Approach
CNS & Neurological Disorders - Drug Targets AMPA Receptor Positive Allosteric Modulators: Potential for the Treatment of Neuropsychiatric and Neurological Disorders
Current Topics in Medicinal Chemistry Interaction of Steroids with the GABA-A Receptor
Current Topics in Medicinal Chemistry Histamine H3 Antagonists for Treatment of Cognitive Deficits in CNS Diseases
Current Topics in Medicinal Chemistry The Clinical Impact of ABCB1 Polymorphisms on the Treatment of Psychiatric Diseases
Current Pharmaceutical Design Editorial (Thematic Issue: Current Research on Cannabis Use Disorder)
Current Pharmaceutical Design Design, Synthesis, Anticonvulsant Activity, Preclinical Study and Pharmacokinetic Performance of N-{[3-(4-chlorophenyl)-4-oxo-3, 4-dihydroquinazolin- 2-yl] methyl}, 2-[(2-isopropyl-5-methyl) 1-cyclo Hexylidene] Hydrazinecarboxamide
Central Nervous System Agents in Medicinal Chemistry The Interplay Among Epilepsy, Parkinson’s Disease and Inflammation: Revisiting the Link through Ca<sup>2+</sup>/cAMP Signalling
Current Neurovascular Research Pharmacotherapy and the Psychobiological Model of Personality: Implications for DSM-5
Current Psychopharmacology The Effect of Pharmacotherapy for Attention Deficit Hyperactivity Disorder on Risk of Seizures in Pediatric Patients as Assessed in an Insurance Claims Database
Current Drug Safety The Neurotachykinin NK1 Receptor – A Novel Target for Diagnostics and Therapy
Current Molecular Imaging (Discontinued) Pathophysiology of Status Epilepticus Induced by Pilocarpine
Central Nervous System Agents in Medicinal Chemistry Comparison of Changes in Cognitive Functions of Post-stroke Patients with the Computer-based Cognitive Intervention (PABLO System) and Conventional Cognitive Intervention (Paper-pencil Method)
Current Psychiatry Research and Reviews Patient’s Perceptions of the Cannabis-psychosis Link - A Systematic Review
Current Pharmaceutical Design The Combination of rTMS and Pharmacotherapy on In Vitro Models: A Mini-Review
CNS & Neurological Disorders - Drug Targets Routine Collection of Patient-Reported Outcomes in an HIV Clinic Setting:The First 100 Patients
Current HIV Research Gamma-Decanolactone Improves Biochemical Parameters Associated with Pilocarpine-Induced Seizures in Male Mice
Current Molecular Pharmacology Effect of Hemodialysis on Pharmacokinetics of Ezogabine/Retigabine and its N-Acetyl Metabolite in Patients with End Stage Renal Disease
Current Clinical Pharmacology Could Event Related Potentials be a Key Prognostic Biomarker of Alzheimer’s Disease?
Current Alzheimer Research Endophenotypes and Biological Markers of Schizophrenia: From Biological Signs of Illness to Novel Treatment Targets
Current Pharmaceutical Design